Lyme disease

JAAPA. 2014 Jun;27(6):48-9. doi: 10.1097/01.JAA.0000446993.79681.08.

Authors

Jami S Smith¹, Rachel Ziegler, Colleen M Didas

Affiliation

¹ Jami S. Smith is academic director of the master's program in medical and healthcare simulation at Drexel University in Philadelphia, Pa., and practices emergency medicine in the Philadelphia area. Rachel Ziegler is a PA student at Arcadia University in Glenside, Pa. Colleen M. Didas is a hospitalist PA at Bassett Medical Center in Cooperstown, N.Y. The authors have disclosed no potential conflicts of interest, financial or otherwise.

PMID: 24853157
DOI: 10.1097/01.JAA.0000446993.79681.08

No abstract available

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Antibiotic Prophylaxis*
Doxycycline / therapeutic use*
Humans
Lyme Disease / complications
Lyme Disease / diagnosis*
Lyme Disease / drug therapy*
Lyme Disease / prevention & control

Substances

Anti-Bacterial Agents
Doxycycline